Beta-interferons and glatiramer acetate: data at 15 years May 26, 2010 Recommend to a Colleague print Disease-modifying therapies used in MS appear to be generally safe after long-term use, according to 15-year results from two new studies. Subscribe to read more It takes 30 seconds or login using your email address Please enter the email address that you registered the newsletter with Continue
